Evidence map›Paper›PMID 37551612›Full record

ArticleAnnals of surgery2024

Prognostic Relevance of Primary Tumor Sidedness in Early-stage Colorectal Cancer: An Integrated Analysis of 4 Randomized Controlled Trials (JCOG2003A).

Akira Ouchi, Ryo Sadachi, Tetsuya Hamaguchi, Shunsuke Tsukamoto, Yasuhiro Shimada, Masafumi Inomata, Yasumasa Takii, Koji Komori, Akio Shiomi, Manabu Shiozawa and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Impact of Liver and Primary Tumor Localization on Survival in Lung Metastasectomy for Colorectal Carcinoma.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 14 institutions in 2 countries.

Akira OuchiDepartment of Gastroenterological Surgery, Aichi Cancer Center Hospital, Aichi, Japan.
Ryo SadachiJapan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Tetsuya HamaguchiDepartment of Medical Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
Shunsuke TsukamotoDepartment of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan.
Yasuhiro ShimadaClinical Oncology Division, Kochi Health Sciences Center, Kochi, Japan.
Masafumi InomataDepartment of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine, Oita, Japan.
Yasumasa TakiiDepartment of Gastroenterological Surgery, Niigata Cancer Center Hospital, Niigata, Japan.
Koji KomoriDepartment of Gastroenterological Surgery, Aichi Cancer Center Hospital, Aichi, Japan.
Akio ShiomiDivision of Colon and Rectal Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
Manabu ShiozawaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
Masayuki OhueDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Jun WatanabeDepartment of Surgery, Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan.
Masaaki ItoDepartment of Colorectal Surgery, National Cancer Center Hospital East, Chiba, Japan.
Yoshiyuki KawashimaDivision of Gastroenterological Surgery, Saitama Cancer Center, Saitama, Japan.
Takaya KobatakeDepartment of Surgery, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.
Hiroaki SoudaDepartment of Gastrointestinal Surgery, Chiba Cancer Center, Chiba, Japan.
Yoshihisa SaidaDepartments of Surgery, Toho University Ohashi Medical Center, Tokyo, Japan.
Tadayoshi HashimotoJapan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Yusuke SanoJapan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Yukihide KanemitsuDepartment of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan.
JCOG Colorectal Cancer Study Group
Japan Clinical Cancer Research Organization · JPAichi Cancer Center · JPNiigata Cancer Center Hospital · JPOita University · JPTokyo National Hospital · JPBreast Cancer Research Foundation · USChiba Cancer Center · JPKanagawa Prefectural Hospital Organization · JPNational Cancer Center Hospital East · JPOsaka International Cancer Institute · JPSaitama Medical University · JPShizuoka Cancer Center · JPToho University · JPYokohama City University Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to determine the genuine prognostic relevance of primary tumor sidedness (PTS) in patients with early-stage colorectal cancer (CRC).

backgroundThe prognostic relevance of PTS in early-stage CRC remains a topic of debate. Several large epidemiological studies investigated survival only and did not consider the risk of recurrence so far.

methodsPatients with stage II/III adenocarcinoma of the colon and upper rectum from 4 randomized controlled trials were analyzed. Survival outcomes were compared according to the tumor location: right-sided (cecum to transverse colon) or left-sided (descending colon to upper rectum).

resultsA total of 4113 patients were divided into a right-sided group (N=1349) and a left-sided group (N=2764). Relapse-free survival after primary surgery was not associated with PTS in all patients and each stage [hazard ratio (HR) adjusted =1.024 (95% CI: 0.886-1.183) in all patients; 1.327 (0.852-2.067) in stage II; and 0.990 (0.850-1.154) in stage III]. Also, overall survival after primary surgery was not associated with PTS in all patients and each stage [HR adjusted =0.879 (95% CI: 0.726-1.064) in all patients; 1.517 (0.738-3.115) in stage II; and 0.840 (0.689-1.024) in stage III]. In total, 795 patients (right-sided, N=257; left-sided, N=538) developed recurrence after primary surgery. PTS was significantly associated with overall survival after recurrence (HR adjusted =0.773, 95% CI: 0.627-0.954).

conclusionsPTS had no impact on the risk of recurrence for stage II/III CRC. Treatment stratification based on PTS is unnecessary for early-stage CRC.

Indexed as

Colorectal NeoplasmsNeoplasm Recurrence, LocalHumansPrognosisRandomized Controlled Trials as TopicRectumRetrospective Studies

Identifiers

PMID37551612
OpenAlexW4385663860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.